Ingram Micro is a global technology distributor that generates approximately $48 billion in annual revenue by serving as a critical link between technology vendors and resellers. As the President of ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Alistair Barr Every time Alistair publishes a story, you’ll get an alert straight to your inbox ...

The U.S. Food and Drug Administration (FDA) has issued draft guidance on its “Platform Technology Designation Program,” which aims to streamline drug development, manufacturing, and marketing ...

AgTech is filled with inspiring breakthroughs—robots enabling precision farming, digital tools that optimize irrigation and fertilization and biological solutions that mimic the efficacy of ...

Technology used within a virtual ward may go beyond this definition. This guidance supports integrated care system (ICS) leads and providers to consider the key requirements when selecting and ...

Microglia are specialized immune cells that make up around 10 % of all cells in the brain and spinal cord. They work by removing pathogenic bacteria, dead cells, aggregated proteins, and soluble ...

Apple Inc. device management platform firm Kandji Inc. today announced that it has changed its name to Iru and launched a new ...

(RTTNews) - Sarepta Therapeutics (SRPT), Wednesday announced that the FDA has designated its rAAVrh74 viral vector used in the investigational gene therapy SRP-9003 for limb-girdle muscular dystrophy ...

The Draft Guidance emphasizes up front that the requirement that the platform technology has the potential to be incorporated in, or utilized by, more than one drug excludes some technologies that the ...

Polyrizon Ltd., a biotech company based in Raanana, Israel, has announced the filing of a divisional patent application for its Trap & Target (T&T) platform technology with the Israel Patent Office.